Livzon Pharmaceutical Group Inc. (SHE:000513)
39.68
-0.62 (-1.54%)
Aug 14, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Chemical Drug Preparations | 6.12B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Chemical Drug Preparations Growth | -6.87% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Active Pharmaceutical Ingredients and Intermediates | 3.25B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Active Pharmaceutical Ingredients and Intermediates Growth | 0.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Traditional Chinese Medicine Preparations | 1.41B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Traditional Chinese Medicine Preparations Growth | -19.27% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostic Reagents and Equipment | 718.43M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostic Reagents and Equipment Growth | 9.02% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biological Products | 170.89M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biological Products Growth | 102.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Activities | 52.01M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Activities Growth | 5.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sales Materials, Processing Charge, Etc. | 51.39M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sales Materials, Processing Charge, Etc. Growth | 11.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Lease | 8.33M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Lease Growth | -7.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 28.52M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 108.69% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sales Materials | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sales Materials Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Processing | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Processing Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Power Supply | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Power Supply Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Technology Transfer | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Drug Preparation Products - Gastrointestinal | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Drug Preparation Products - Gastrointestinal Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Bulk Medicines and Intermediates | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Bulk Medicines and Intermediates Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Drug Preparation Products - Gonadotropic Hormones | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Drug Preparation Products - Gonadotropic Hormones Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Drug Preparation Products - Antibiotics | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Drug Preparation Products - Antibiotics Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Drug Preparation Products - Others | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Drug Preparation Products - Others Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Drug Preparation Products - Cardio-cerebral Vascular | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Drug Preparation Products - Cardio-cerebral Vascular Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
China | 9.98B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | -7.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Overseas | 1.72B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Overseas Growth | 9.69% |
Log In |
Log In |
Log In |
Log In | Upgrade
|